International Association for Child and Adolescent Psychiatry and Allied Professions Congress

Session Details

Symposium: Neurotransmitters, ADHD and treatment with Reboxetine

Wednesday, 13 September 2006 16:30 -18:00

Corryong 5

Chair Florian Zepf Dept. of Child and Adolescent Psychiatry & Psychotherapy - J.W. Goethe UniversityGermany
Co-Chair Daryl Efron  Australia

The relationship between Attention Deficit Hyperactivity Disorder, disruptive behaviour symptoms and monoamine oxidase B in platelets
  • Kerstin Malmberg, Dept of woman and child health, Karolinska Institutet, Sweden
  • Mood changes in male patients with ADHD after an acute serotonergic dysfunction: Effects of rapid tryptophan depletion
  • Florian Daniel Zepf, Department of Child and Adolescent Psychiatry and Psychotherapy, J.W. Goethe University of Frankfurt am Main, Germany
  • An open-label trial of Reboxetine in children and adolescents with Attention-Deficit/Hyperactivity Disorder
  • Mehdi Tehrani-Doost, 1-Tehran University of Medical Sciences, deparment of psychiatry; 2-Institute for Cognitive Science Studies, Iran
  • Published on Thursday, 7 September 2006 by the Professional Conference Organiser